EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Zilian Ointment Promotes Diabetic Wound Healing via Akt/HIF‐1 α –Mediated Angiogenesis

Cheng Qin iD, Yiwen Zhang iD, Duhua Chen iD, Jin Xu iD, Jing Yang iD, Fei Liu iD, Qin Li, Xiang Li iD, Jianzhou Ye iD, Xuesong Yang iD

Journal of Diabetes Research · 2026

DOI: 10.1155/jdr/9928022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, 2026. Verfasst von Cheng Qin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, China. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Wound Healing, Proto-Oncogene Proteins c-akt, Neovascularization, Physiologic. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yunnan Provincial Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Persistent inflammation, defective angiogenesis, and metabolic dysfunction impede diabetic wound repair. Although Zilian ointment (ZLO) is clinically applied to wounds, its activity in diabetic wounds and the associated molecular basis remain incompletely understood. We therefore assessed the reparative effects of ZLO and examined the signaling events potentially involved.

Methods

UHPLC‐MS was used to characterize the chemical profile of ZLO, and network pharmacology was integrated to identify potential molecular targets and pathways. A diabetic wound model was applied to assess the reparative effects of ZLO on wound closure and tissue regeneration. Histological and immunohistochemical approaches were used to evaluate angiogenesis, macrophage polarization, and the expression of hypoxia/glycolysis‐associated proteins, including HIF‐1 α , GLUT1, LDHA, PKM2, and VEGFA. AKT/HIF‐1 α pathway activation was further examined by western blotting.

Results

ZLO‐treated db/db mice displayed a smaller residual wound area and more complete histological repair, including greater epithelial coverage, granulation tissue formation, and collagen accumulation. Treatment was accompanied by stronger CD31 and VEGFA signals, together with a macrophage profile characterized by more F4/80 + CD206 + cells and fewer F4/80 + iNOS + cells. KEGG enrichment and PPI network analyses highlighted HIF‐1 signaling and AKT1, respectively. In wound sections, ZLO increased the expression of HIF‐1 α , GLUT1, PKM2, and VEGFA. Immunoblotting further revealed an elevated p‐AKT/AKT ratio and recovery of HIF‐1 α and VEGFA protein levels.

Conclusion

ZLO facilitates diabetic wound repair, with its therapeutic effects potentially associated with AKT/HIF‐1 α –linked metabolic regulation and enhanced angiogenic responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitWound HealingProto-Oncogene Proteins c-aktNeovascularization, PhysiologicDiabetes Mellitus, ExperimentalDrugs, Chinese HerbalAnimalsSignal TransductionOintmentsMiceMaleVascular Endothelial Growth Factor AMice, Inbred C57BLMacrophages

Stichwörter der Autor:innen

AKT/HIF-1α signalingZilian ointmentangiogenesisdiabetic wound healingglycolysis

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitProto-Oncogene Proteins c-aktOintmentsHif1a protein, mouseVascular Endothelial Growth Factor ADrugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Dermatology, The First Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, China.
  • Department of Dermatology, The First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, China, ynutcm.edu.cn.
  • Department of Dermatology, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, China, yn-tcm-hospital.com.
  • Department of Plastic & Reconstructive Surgery, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Department of Dermatology and Venereology, Linquan County People's Hospital, Fuyang, China.

ORCID-Profile: Cheng Qin, Yiwen Zhang, Duhua Chen, Jin Xu, Jing Yang, Fei Liu, Xiang Li, Jianzhou Ye, Xuesong Yang

Förderung

  • Yunnan Provincial Science and Technology Department

Zitieren

APA

Qin, C., Zhang, Y., Chen, D., Xu, J., Yang, J., Liu, F., Li, Q., Li, X., Ye, J., & Yang, X. (2026). Zilian Ointment Promotes Diabetic Wound Healing via Akt/HIF‐1 α –Mediated Angiogenesis. Journal of Diabetes Research. https://doi.org/10.1155/jdr/9928022

Vancouver

Qin C, Zhang Y, Chen D, Xu J, Yang J, Liu F, et al. Zilian Ointment Promotes Diabetic Wound Healing via Akt/HIF‐1 α –Mediated Angiogenesis. Journal of Diabetes Research. 2026. doi:10.1155/jdr/9928022

BibTeX
@article{Qin2026,
  author = {Qin, Cheng and Zhang, Yiwen and Chen, Duhua and Xu, Jin and Yang, Jing and Liu, Fei and Li, Qin and Li, Xiang and Ye, Jianzhou and Yang, Xuesong},
  title = {Zilian Ointment Promotes Diabetic Wound Healing via Akt/HIF‐1 α –Mediated Angiogenesis},
  journal = {Journal of Diabetes Research},
  year = {2026},
  doi = {10.1155/jdr/9928022}
}
Kostenlos starten →